Investor Relations

MannKind Corporation (Nasdaq:MNKD ) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer... More >>

• Press Releases
• Annual Reports
• Quarterly Reports
• 2009 Annual Meeting Materials

Committee Charters	Policy Statements
Audit Committee	Policy Regarding Stockholder Recommendations of Director Nominees
Compensation Committee	Process of Securityholder Communications with the Board of Directors
Nominating & Corporate Governance Committee

 Adobe Acrobat Reader
Read Adobe PDF files on your desktop or on the Web.